Arvinas
Focus: Arvinas is a New Haven-based biotechnology company pioneering bifunctional small molecules (PROTACs) for protein degradation, with a focused oncology pipeline in breast cancer, prostate cancer, and solid tumors.
Profile data last refreshed 1h ago · AI intelligence enriched 2w ago
Open Jobs
3-2 this month
Stable — net -2 jobs in 30d
0 added, 2 removed. Backfill posture.
Should You Work at Arvinas?
AI assessmentArvinas offers rare technical differentiation in protein degradation for oncology specialists, but limited hiring and early-stage pipeline imply career growth depends heavily on vepdegestrant's Phase 3 success.
Why Work Here
- Lead a novel modality: PROTACs represent a differentiated mechanism in oncology with only a handful of companies pursuing this approach, offering technical depth and intellectual challenge.
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
ARV-471 in combination with Everolimus
Breast CancerClinical Trials (1)
NCT05501769ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
Phase 1Help build intelligence for Arvinas
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.